Ultralife Corporation
ULBI
$6.67
$0.010.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.26% | -10.56% | 118.54% | 296.37% | 3,602.69% |
| Total Depreciation and Amortization | 16.27% | 6.29% | -1.03% | -4.70% | -8.82% |
| Total Amortization of Deferred Charges | 118.75% | 42.19% | 1.69% | 25.49% | 42.22% |
| Total Other Non-Cash Items | -35.95% | 14.38% | 25.30% | 135.18% | 1,409.05% |
| Change in Net Operating Assets | 158.09% | 135.21% | 113.62% | -15.84% | -336.63% |
| Cash from Operations | 525.12% | 762.42% | 677.39% | 311.69% | 440.91% |
| Capital Expenditure | -1.15% | 24.29% | -27.38% | -7.78% | -34.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,979.81% | -1,857.45% | -27.38% | -7.78% | -34.46% |
| Total Debt Issued | 1,011.11% | 658.62% | -84.00% | -51.64% | 17.86% |
| Total Debt Repaid | -764.47% | -758.23% | -540.40% | -422.63% | 0.00% |
| Issuance of Common Stock | -32.02% | 60.18% | 108.17% | 4,703.08% | 64,333.33% |
| Repurchase of Common Stock | -- | -- | -100.00% | -100.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 9.33% | -- | -- |
| Cash from Financing | 648.08% | 443.90% | -482.74% | -411.57% | 253.88% |
| Foreign Exchange rate Adjustments | 114.37% | 111.26% | 49.74% | 71.77% | 49.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.71% | -175.01% | -159.46% | -150.27% | 1,109.89% |